Epis NexLab

Epis NexLab, a subsidiary of Samsung Epis Holdings, focuses on building a biotechnology platform to drive future growth. The company plans to transform its highly scalable core technology into platform-based capabilities to develop multiple new drug candidate molecules. Its main business areas include the development of several core technology platforms related to peptides. Through these efforts, the company aims to identify new growth drivers in the biopharmaceutical field and grow into a leading biotechnology company in the next-generation therapeutic technology sector. Samsung Epis Holdings supports its goal of becoming a global leader in the biopharmaceutical market.